SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16291416
Source:
http://linkedlifedata.com/resource/pubmed/id/16291416
Search
Subject
(
67
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0009429
,
umls-concept:C0011860
,
umls-concept:C0017628
,
umls-concept:C0034656
,
umls-concept:C0036043
,
umls-concept:C0071097
,
umls-concept:C0205169
,
umls-concept:C0205195
,
umls-concept:C0556895
,
umls-concept:C2003521
,
umls-concept:C2587213
,
umls-concept:C2603343
pubmed:issue
9
pubmed:dateCreated
2005-11-18
pubmed:abstractText
Few large randomized controlled trials have assessed the value of adding insulin to an oral antidiabetic drug regimen.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7706726
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Glyburide
,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin
,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones
,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
,
http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0149-2918
pubmed:author
pubmed-author:ChowChun-ChungCC
,
pubmed-author:FilipczakRobertR
,
pubmed-author:JoshiPankajP
,
pubmed-author:LertoftBenedikteB
,
pubmed-author:RastamJacobJ
,
pubmed-author:RazItamarI
,
pubmed-author:ShabanJosephJ
,
pubmed-author:StranksStephenS
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1432-43
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16291416-Blood Glucose
,
pubmed-meshheading:16291416-Diabetes Mellitus, Type 2
,
pubmed-meshheading:16291416-Drug Therapy, Combination
,
pubmed-meshheading:16291416-Female
,
pubmed-meshheading:16291416-Glyburide
,
pubmed-meshheading:16291416-Hemoglobin A, Glycosylated
,
pubmed-meshheading:16291416-Humans
,
pubmed-meshheading:16291416-Hypoglycemic Agents
,
pubmed-meshheading:16291416-Insulin
,
pubmed-meshheading:16291416-Male
,
pubmed-meshheading:16291416-Thiazolidinediones
,
pubmed-meshheading:16291416-Time Factors
,
pubmed-meshheading:16291416-Triglycerides
,
pubmed-meshheading:16291416-Weight Gain
pubmed:year
2005
pubmed:articleTitle
Efficacy and safety of biphasic insulin aspart 30 combined with pioglitazone in type 2 diabetes poorly controlled on glibenclamide (glyburide) monotherapy or combination therapy: an 18-week, randomized, open-label study.
pubmed:affiliation
Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem, Israel. ntv502@netvision.net.il
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial
,
Research Support, Non-U.S. Gov't
,
Multicenter Study